Dmitry Reykhart | TalkMarkets | Page 1
Chairman of the Board of Directors, Ruthenium Global Pharma Fund
Contributor's Links: Ruthenium Global Pharma Fund
Founder, Chairman of the Board of Directors - Ruthenium Global Pharma Fund, Doctor of Biological Sciences

Articles

Latest Posts
1 to 1 of 1 Posts
Top Biotech Companies Are Making Progress In The Fight Against Alzheimer’s Disease
The estimated cost of Alzheimer's disease and related dementia care in 2021 was $355B. Investing in the top companies that are progressing toward a treatment for Alzheimer’s can bring handsome investment returns.
1 to 1 of 1 Posts